Paclitaxel, bevacizumab, and everolimus/placebo as first-line treatment for patients with metastatic HER2-negative breast cancer: a randomized placebo-controlled phase II trial of the Sarah Cannon Research Institute
| Image |  |
|---|---|
| Description | scientific article published on 12 October 2015 |
| Author/s |
author: John D Hainsworth Denise A Yardley Joyce O'Shaughnessy |
| Publication date | October 12, 2015 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |